Back

A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy?

European Heart Journal - Cardiovascular Pharmacotherapy

2 November 2020
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Session
Great Debate: anti-inflammatory therapy should be a part of atherosclerotic cardiac disease treatment
1 September 2025
thumbnail
Congress Presentation
Non-statin lipid-lowering therapy in coronary atherosclerosis regression: A meta-analysis and meta-regression.
30 August 2020
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Webinar
Post-ACS management of dyslipidaemia: tips and tricks from real world experiences
16 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources